Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.

Irwin ML, Duggan C, Wang CY, Smith AW, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R.

J Clin Oncol. 2011 Jan 1;29(1):47-53. doi: 10.1200/JCO.2010.28.4752. Epub 2010 Nov 29.

2.

Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study.

George SM, Bernstein L, Smith AW, Neuhouser ML, Baumgartner KB, Baumgartner RN, Ballard-Barbash R.

Breast Cancer Res Treat. 2014 Aug;146(3):647-55. doi: 10.1007/s10549-014-3048-x. Epub 2014 Jul 24.

PMID:
25056184
3.

Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study.

Irwin ML, Smith AW, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD, Baumgartner RN, Baumgartner KB, Bernstein L.

J Clin Oncol. 2008 Aug 20;26(24):3958-64. doi: 10.1200/JCO.2007.15.9822.

4.

Associations of insulin resistance and adiponectin with mortality in women with breast cancer.

Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A.

J Clin Oncol. 2011 Jan 1;29(1):32-9. doi: 10.1200/JCO.2009.26.4473. Epub 2010 Nov 29.

6.

Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors.

Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2881-8.

7.

Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults.

Patel N, Taveira TH, Choudhary G, Whitlatch H, Wu WC.

J Am Heart Assoc. 2012 Dec;1(6):e003152. doi: 10.1161/JAHA.112.003152. Epub 2012 Dec 19.

8.

Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.

Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):161-4.

9.

Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.

Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, Goodwin PJ.

Breast Cancer Res Treat. 2005 Nov;94(2):135-44.

PMID:
16261412
10.

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD.

J Natl Cancer Inst. 2009 Jan 7;101(1):48-60. doi: 10.1093/jnci/djn415. Epub 2008 Dec 30.

11.

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N.

J Clin Oncol. 2002 Jan 1;20(1):42-51.

PMID:
11773152
12.

A prospective study of plasma C-peptide and colorectal cancer risk in men.

Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ.

J Natl Cancer Inst. 2004 Apr 7;96(7):546-53.

PMID:
15069117
13.

Energy balance, insulin resistance biomarkers, and breast cancer risk.

Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F, Gao YT, Zheng W.

Cancer Detect Prev. 2007;31(3):214-9. Epub 2007 Jul 23.

14.

Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?

Borugian MJ, Sheps SB, Kim-Sing C, Van Patten C, Potter JD, Dunn B, Gallagher RP, Hislop TG.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1163-72.

15.

Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.

Hsu CN, Chang CH, Lin YS, Lin JW, Caffrey JL.

PLoS One. 2013;8(2):e55625. doi: 10.1371/journal.pone.0055625. Epub 2013 Feb 6.

16.

Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.

Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, Weltzien E.

Cancer Causes Control. 2008 Dec;19(10):1319-28. doi: 10.1007/s10552-008-9203-0. Epub 2008 Aug 28.

17.

Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjønneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Téhard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH, Bueno-de-Mesquita BH, González CA, Ardanaz E, Larranaga N, Garcia CM, Navarro C, Quirós JR, Key T, Allen N, Bingham S, Khaw KT, Slimani N, Riboli E, Kaaks R.

Int J Cancer. 2006 Aug 1;119(3):659-67.

18.

Prolonged Nightly Fasting and Breast Cancer Prognosis.

Marinac CR, Nelson SH, Breen CI, Hartman SJ, Natarajan L, Pierce JP, Flatt SW, Sears DD, Patterson RE.

JAMA Oncol. 2016 Aug 1;2(8):1049-55. doi: 10.1001/jamaoncol.2016.0164.

PMID:
27032109
19.

Population-based, case-control study of blood C-peptide level and breast cancer risk.

Yang G, Lu G, Jin F, Dai Q, Best R, Shu XO, Chen JR, Pan XY, Shrubsole M, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1207-11.

20.

Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N.

J Clin Oncol. 2012 Jan 10;30(2):164-71. doi: 10.1200/JCO.2011.36.2723. Epub 2011 Dec 12.

PMID:
22162568

Supplemental Content

Support Center